Literature DB >> 23640708

Ang(1-7) treatment attenuates β-cell dysfunction by improving pancreatic microcirculation in a rat model of Type 2 diabetes.

L Yuan1, Y Li, G Li, Y Song, X Gong.   

Abstract

AIMS: Pancreatic microcirculation plays a pivotal role in the physiological function and survival of β-cells. Ang(1- 7) is a novel component of the renin angiotensin system (RAS) that has beneficial effects on microcirculation. In the present study, we investigated the effects of systemic Ang(1-7) administration (with or without its receptor Mas antagonist A- 779) on pancreatic microcirculation and β-cell function.
METHODS: These effects were studied in vivo using a rat model of Type 2 diabetes (T2DM). Pancreatic microcirculation and islet microvessel density were measured; and β-cell function, insulin content, and the apoptosis of islet cells were assessed, respectively. Additionally, we evaluated endothelial nitric oxide synthase (eNOS) expression and nitric oxide (NO) concentration in islets.
RESULTS: After Ang(1-7) intervention, pancreatic microcirculation and intra-islet microvessel density were significantly improved (p<0.05), and more importantly, first-phase insulin secretion of β-cells as well as relative insulin content in islets were increased, and the amount of apoptotic islet cells was decreased (p<0.05). And eNOS expression and NO release were up-regulated in pancreatic islets by Ang(1-7) administration (p<0.05). These positive effects of Ang(1-7) were prevented by the addition of A-779 (p<0.05).
CONCLUSIONS: Our findings suggest that systemic Ang(1-7) treatment could attenuate β-cell dysfunction and ameliorate islet cell apoptosis in T2DM rats by improving pancreatic microcirculation, perhaps through the mechanism of endothelial vasodilation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23640708     DOI: 10.3275/8951

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  29 in total

1.  Islet endothelial cells and pancreatic beta-cell proliferation: studies in vitro and during pregnancy in adult rats.

Authors:  Magnus Johansson; Göran Mattsson; Arne Andersson; Leif Jansson; Per-Ola Carlsson
Journal:  Endocrinology       Date:  2006-01-26       Impact factor: 4.736

2.  Validation of the multiple colored microsphere technique for regional blood flow measurements in newborn piglets.

Authors:  B Walter; R Bauer; E Gaser; U Zwiener
Journal:  Basic Res Cardiol       Date:  1997-06       Impact factor: 17.165

3.  Effects of renin-angiotensin system blockade on the islet morphology and function in rats with long-term high-fat diet.

Authors:  Li Yuan; Xin Li; Jin Li; Hai-Ling Li; Suo-Suo Cheng
Journal:  Acta Diabetol       Date:  2010-07-14       Impact factor: 4.280

4.  Islet microvasculature in islet hyperplasia and failure in a model of type 2 diabetes.

Authors:  Xianquan Li; Lanjing Zhang; Sasha Meshinchi; Claudia Dias-Leme; Diane Raffin; Jeffery D Johnson; Mary K Treutelaar; Charles F Burant
Journal:  Diabetes       Date:  2006-11       Impact factor: 9.461

5.  Effects of renin-angiotensin system blockade on islet function in diabetic rats.

Authors:  L Yuan; X Li; G-L Xu; C-J Qi
Journal:  J Endocrinol Invest       Date:  2010-01       Impact factor: 4.256

6.  Effects of external ATP on Ca(2+) signalling in endothelial cells isolated from mouse islets.

Authors:  Bo Hellman; Leif Jansson; Heléne Dansk; Eva Grapengiesser
Journal:  Endocrine       Date:  2007-09-29       Impact factor: 3.633

7.  Endothelial dysfunction through genetic deletion or inhibition of the G protein-coupled receptor Mas: a new target to improve endothelial function.

Authors:  Concepcion Peiró; Susana Vallejo; Florian Gembardt; Verónica Azcutia; Silvia Heringer-Walther; Leocadio Rodríguez-Mañas; Heinz-Peter Schultheiss; Carlos F Sánchez-Ferrer; Thomas Walther
Journal:  J Hypertens       Date:  2007-12       Impact factor: 4.844

8.  Telmisartan ameliorates hyperglycemia and metabolic profile in nonobese Cohen-Rosenthal diabetic hypertensive rats via peroxisome proliferator activator receptor-gamma activation.

Authors:  Firas Younis; Naftali Stern; Rona Limor; Yoram Oron; Sarah Zangen; Talma Rosenthal
Journal:  Metabolism       Date:  2010-01-13       Impact factor: 8.694

9.  Improved islet morphology after blockade of the renin- angiotensin system in the ZDF rat.

Authors:  Christos Tikellis; Peter J Wookey; Riccardo Candido; Sof Andrikopoulos; Merlin C Thomas; Mark E Cooper
Journal:  Diabetes       Date:  2004-04       Impact factor: 9.461

10.  Chronic infusion of angiotensin-(1-7) improves insulin resistance and hypertension induced by a high-fructose diet in rats.

Authors:  Jorge F Giani; Marcos A Mayer; Marina C Muñoz; Ezequiel A Silberman; Christian Höcht; Carlos A Taira; Mariela M Gironacci; Daniel Turyn; Fernando Pablo Dominici
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-11-11       Impact factor: 4.310

View more
  15 in total

1.  Lack of weight gain after angiotensin AT1 receptor blockade in diet-induced obesity is partly mediated by an angiotensin-(1-7)/Mas-dependent pathway.

Authors:  Johanna Schuchard; Martina Winkler; Ines Stölting; Franziska Schuster; Florian M Vogt; Jörg Barkhausen; Christoph Thorns; Robson A Santos; Michael Bader; Walter Raasch
Journal:  Br J Pharmacol       Date:  2015-06-12       Impact factor: 8.739

2.  Hypertensive urgencies and emergencies: Misconceptions and pitfalls.

Authors:  Fabio Angeli; Gianpaolo Reboldi; Paolo Verdecchia
Journal:  Eur J Intern Med       Date:  2019-11-06       Impact factor: 4.487

Review 3.  The ACE2/Angiotensin-(1-7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7).

Authors:  Robson Augusto Souza Santos; Walkyria Oliveira Sampaio; Andreia C Alzamora; Daisy Motta-Santos; Natalia Alenina; Michael Bader; Maria Jose Campagnole-Santos
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

4.  High-fat diet-induced glucose dysregulation is independent of changes in islet ACE2 in mice.

Authors:  Harshita Chodavarapu; Kavaljit H Chhabra; Huijing Xia; Vinayak Shenoy; Xinping Yue; Eric Lazartigues
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-11-02       Impact factor: 3.619

Review 5.  The islet endothelial cell: a novel contributor to beta cell secretory dysfunction in diabetes.

Authors:  Meghan F Hogan; Rebecca L Hull
Journal:  Diabetologia       Date:  2017-04-10       Impact factor: 10.122

6.  Neprilysin Is Required for Angiotensin-(1-7)'s Ability to Enhance Insulin Secretion via Its Proteolytic Activity to Generate Angiotensin-(1-2).

Authors:  Gurkirat S Brar; Breanne M Barrow; Matthew Watson; Ryan Griesbach; Edwina Choung; Andrew Welch; Bela Ruzsicska; Daniel P Raleigh; Sakeneh Zraika
Journal:  Diabetes       Date:  2017-05-30       Impact factor: 9.461

7.  Sex differences in metabolic effects of angiotensin-(1-7) treatment in obese mice.

Authors:  Melissa C White; Amanda J Miller; Justin Loloi; Sarah S Bingaman; Biyi Shen; Ming Wang; Yuval Silberman; Sarah H Lindsey; Amy C Arnold
Journal:  Biol Sex Differ       Date:  2019-07-17       Impact factor: 5.027

Review 8.  ACE2, angiotensin 1-7 and skeletal muscle: review in the era of COVID-19.

Authors:  Koichi Yamamoto; Hikari Takeshita; Hiromi Rakugi
Journal:  Clin Sci (Lond)       Date:  2020-11-27       Impact factor: 6.124

Review 9.  Functional ACE2 deficiency leading to angiotensin imbalance in the pathophysiology of COVID-19.

Authors:  Joshua R Cook; John Ausiello
Journal:  Rev Endocr Metab Disord       Date:  2021-07-01       Impact factor: 9.306

Review 10.  Teachings from COVID-19 and aging-An oxidative process.

Authors:  Misha Zarbafian; Steven Dayan; Sabrina G Fabi
Journal:  J Cosmet Dermatol       Date:  2020-10-12       Impact factor: 2.189

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.